Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3401 - 3425 of 6046 in total
Sub Class ▼ LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB08
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Globoside I/Cytolipin K(d18:1/26:1(17Z))
44260179 1364.890793 C70H128N2O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC00
  • Forssman antigen
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1161 18056
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC03
  • Forssman antigen(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260182 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC04
  • Forssman antigen(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260183 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC05
  • Forssman antigen(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260184 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC06
  • Forssman antigen(d18:1/26:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260185 1569.985817 C78H143N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC07
  • Forssman antigen(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260186 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC08
  • Forssman antigen(d18:1/26:1(17Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260187 1567.970167 C78H141N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD00
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Para-Forssman x3b
GSG1338
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD01
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Para-Forssman x3b(d18:1/16:0)
44260188 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD02
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Para-Forssman x3b(d18:1/18:0)
44260189 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD03
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Para-Forssman x3b(d18:1/20:0)
44260190 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD04
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Para-Forssman x3b(d18:1/22:0)
44260191 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD05
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Para-Forssman x3b(d18:1/24:0)
44260192 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD06
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Para-Forssman x3b(d18:1/26:0)
44260193 1569.985817 C78H143N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD07
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Para-Forssman x3b(d18:1/24:1(15Z))
44260194 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD08
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Para-Forssman x3b(d18:1/26:1(17Z))
44260195 1567.970167 C78H141N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE00
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • SSEA-3 antigen
GSG1197 62571
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE01
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • SSEA-3 antigen(d18:1/16:0)
44260196 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE02
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • SSEA-3 antigen(d18:1/18:0)
44260197 1416.834068 C68H124N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE03
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • SSEA-3 antigen(d18:1/20:0)
44260198 1444.865368 C70H128N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE04
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • SSEA-3 antigen(d18:1/22:0)
44260199 1472.896668 C72H132N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE05
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • SSEA-3 antigen(d18:1/24:0)
44260200 1500.927968 C74H136N2O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024